Aarti Pharmalabs fundamental analysis
AARTIPHARM
740.1
2.00 (-0.27%)Last updated on 3 Jan, 2026 | 13:09 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Aarti Pharmalabs Fundamentals
P/E Ratio
28.07
P/B Ratio
3.29
Div. Yield
0.67
Sector P/E
72.47
Sector P/B
1.02
Sec. Div. Yield
0.56
Aarti Pharmalabs Fundamentals is currently trading with a P/E Ratio of 28.07, compared to the sector average of 72.47. Its P/B Ratio stands at 3.29, while the sector’s is 1.02. In terms of returns, the stock offers a Dividend Yield of 0.67%, which is than the sector’s 0.56%.
Aarti Pharmalabs Score Card
Price
Expensive
Growth
Good
Quality
Good
Management
Good
On its scorecard, Aarti Pharmalabs reflects: Price – Expensive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
